The oral allergy syndrome: Improved diagnostic and treatment methods

Current Opinion in Allergy and Clinical Immunology

Volumn 5, Issue 3, 2005, Pages 267-273

  Mari, Adriano ^a,d   Ballmer Weber, Barbara K ^b   Vieths, Stefan ^c  

^a Pediatric National Health Service   (Italy)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c PAUL EHRLICH INSTITUT   (Germany)

^d NONE   (Italy)

Author keywords

Allergen; Co recognition; Cross reactivity; Food allergy; Oral allergy syndrome; Specific immunotherapy

Indexed keywords

ACTINIDIN; ALLERGEN; ANTIHISTAMINIC AGENT;

APPLE; BIRCH; BIRCH POLLEN; CLINICAL FEATURE; CROSS REACTION; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FOOD ALLERGY; FRUIT; HAZELNUT; HUMAN; IMMUNOREACTIVITY; IMMUNOTHERAPY; KIWIFRUIT; LETTUCE; ORAL ALLERGY SYNDROME; POLLEN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SAFETY; SUBCUTANEOUS IMMUNOTHERAPY; SYNDROME;

EID: 18844455033     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.all.0000168793.27948.b0     Document Type: Review

References (54)

1. Pastorello EA, Ortolani C. Oral allergy syndrome. In: Metcalfe DD, Sampson HA, Simon RA, editors. Food allergy: adverse reactions to food and food additives. Cambridge: Blackwell Science; 1997. pp. 221-234.
2. Eigenmann PA, Pastore FD, Zamora SA. An Internet-based survey of anaphylactic reactions to foods. Allergy 2001; 56:540-543.
3. Ma S, Sicherer SH, Nowak-Wegrzyn A. A survey on the management of pollen-food allergy syndrome in allergy practices. J Allergy Clin Immunol 2003; 112:784-788.
4. Roehr CC, Edenharter G, Reimann S, et al. Food allergy and non-allergic food hypersensitivity in children and adolescents. Clin Exp Allergy 2004; 34:1534-1541.
5. Sicherer SH, Munoz-Furlong A, Sampson HA. Prevalence of seafood allergy in the United States determined by a random telephone survey. J Allergy Clin Immunol 2004; 114:159-165.
6. Yamamoto T, Asakura K, Shirasaki H, et al. Oral allergy syndrome among patients with birch pollinosis in Sapporo. Arerugi 2004; 53:435-442.
7. Eriksson NE, Moller C, Werner S, et al. Self-reported food hypersensitivity in Sweden, Denmark, Estonia, Lithuania, and Russia. J Investig Allergol Clin Immunol 2004; 14:70-79.
8. Rossi RE, Monasterolo G, Monasterolo S. Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles. Allergy 2003; 58:929-932.
9. Mari A, Wallner M, Ferreira F. Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4). Clin Exp Allergy 2003; 33:1419-1428.
10. Bolhaar ST, van Ree R, Bruijnzeel-Koomen CA, et al. Allergy to jackfruit: a novel example of Bet v 1-related food allergy. Allergy 2004; 59:1187-1192. The clinical reactivity to a fruit bearing a Bet v 1-related molecule is described for the first time as it was consumed outside the original geographical area of cultivation.
11. Skamstrup Hansen K, Ballmer-Weber BK, et al. Roasted hazelnuts: allergenic activity evaluated by double-blind, placebo-controlled food challenge. Allergy 2003; 58:132-138.
12. Maleki SJ. Food processing: effects on allergenicity. Curr Opin Allergy Clin Immunol 2004; 4:241-245. This is an exhaustive review on the effect of food processing on IgE binding to allergens.
13. Fiocchi A, Restani P, Bernardo L, et al. Tolerance of heat-treated kiwi by children with kiwifruit allergy. Pediatr Allergy Immunol 2004; 15:454-458. This describes a study on thermal liability of kiwi allergens.
14. Jorde W, Jorde UP. Antigen resorption from the gastrointestinal tract: a historical perspective on the pathophysiological foundation of modern sublingual/oral immunotherapy. Chem Immunol Allergy 2003; 82:25-32.
15. Bagnasco M, Morbelli S, Altrinetti V, et al. Allergen biodistribution in humans. Chem Immunol Allergy 2003; 82:33-43.
16. Eriksson NE, Moller C, Werner S, et al. The hazards of kissing when you are food allergic: a survey on the occurrence of kiss-induced allergic reactions among 1139 patients with self-reported food hypersensitivity. J Investig Allergol Clin Immunol 2003; 13:149-154.
17. Steensma DP. The kiss of death: a severe allergic reaction to a shellfish induced by a good-night kiss. Mayo Clin Proc 2003; 78:221-222.
18. Tabar A, Alvarez-Puebla M, Gomez B, et al. Diversity of asparagus allergy: clinical and immunological features. Clin Exp Allergy 2004; 34:131-136. OAS caused by LTP is reported in one subject. Respiratory symptoms caused by inhalation of the same molecule are reported.
19. Willerroider M, Fuchs H, Ballmer-Weber BK, et al. Cloning and molecular and immunological characterisation of two new food allergens, Cap a 2 and Lye e 1, profilins from bell pepper (Capsicum annuum) and tomato (Lycopersicon esculentum). Int Arch Allergy Immunol 2003; 131:245-255.
20. Scheurer S, Lauer I, Foetisch K, et al. Strong allergenicity of Pru av 3, the lipid transfer protein from cherry, is related to high stability against thermal processing and digestion. J Allergy Clin Immunol 2004; 114:900-907. A further characterization of the cherry LTP. A high stability level to thermal and simulated gastric fluid digestion is reported.
21. Cadot P, Kochuyt AM, van Ree R, Ceuppens JL. Oral allergy syndrome to chicory associated with birch pollen allergy. Int Arch Allergy Immunol 2003; 131:19-24.
22. Antico A, Zoccatelli G, Marcotulli C, Curioni A. Oral allergy syndrome to fig. Int Arch Allergy Immunol 2003; 131:138-142.
23. Focke M, Hemmer W, Wohrl S, et al. Cross-reactivity between Ficus benja mina latex and fig fruit in patients with clinical fig allergy. Clin Exp Allergy 2003; 33:971-977.
24. Schocker F, Luttkopf D, Scheurer S, et al. Recombinant lipid transfer protein Cor a 8 from hazelnut: a new tool for in vitro diagnosis of potentially severe hazelnut allergy. J Allergy Clin Immunol 2004; 113:141-147. Reporting cloning of the LTP from hazelnut gives a full insight into a hazelnut allergen inducing severe food allergy symptoms.
25. Lucas JS, Grimshaw KE, Collins K, et al. Kiwi fruit is a significant allergen and is associated with differing patterns of reactivity in children and adults. Clin Exp Allergy 2004; 34:1115-1121. This DBPCFC-based study carefully evaluated clinical reactivity of subjects reporting symptoms on kiwi ingestion. Two-thirds of sensitized subjects reported OAS, but more severe systemic reactions are associated.
26. Aleman A, Sastre J, Quirce S, et al. Allergy to kiwi: a double-blind, placebo-controlled food challenge study in patients from a birch-free area. J Allergy Clin Immunol 2004; 113:543-550. This DBPCFC-based study was carried out to identify kiwi allergic subjects and to study their IgE reactivity by immunoblot.
27. Bublin M, Mari A, Ebner C, et al. IgE sensitization profiles toward green and gold kiwifruits differ among patients allergic to kiwifruit from 3 European countries. J Allergy Clin Immunol 2004; 114:1169-1175. This was the first extensive study reporting allergenic molecules in gold kiwi fruit, compared with those present in the green one. Data on reactivity of patients from different European countries are reported.
28. Miguel-Moncin M, Krail M, Scheurer S, et al. Lettuce anaphylaxis: identification of a lipid transfer protein as the major allergen. Allergy 2003; 58:511-517.
29. Figueredo E, Cuesta-Herranz J, De Miguel J, et al. Clinical characteristics of melon (Cucumis melo) allergy. Ann Allergy Asthma Immunol 2003; 91:303-308.
30. Rodriguez-Perez R, Crespo JF, Rodriguez J, Salcedo G. Profilin is a relevant melon allergen susceptible to pepsin digestion in patients with oral allergy syndrome. J Allergy Clin Immunol 2003; 111:634-639.
31. Mittag D, Akkerdaas J, Ballmer-Weber BK, et al. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy. J Allergy Clin Immunol 2004; 114:1410-1417. This was the first and most comprehensive study on biochemistry, immunochemistry, cloning and clinical data of a new Bet v 1-related molecule.
32. Mittag D, Vieths S, Vogel L, et al. Soybean allergy in patients allergic to birch pollen: Clinical investigation and molecular characterization of allergens. J Allergy Clin Immunol 2004; 113:148-154. This presents a complete definition of molecular, immunochemical, and clinical features of a Bet v 1 homologous PR-10 protein from soybean, including an extensive evaluation of the allergen concentration in products, during ripening and storage.
33. Kleine-Tebbe J, Vogel L, Crowell DN, et al. Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1 - related PR-10 protein in soybean, SAM22. J Allergy Clin Immunol 2002; 110:797-804.
34. Scholl I, Jensen-Jarolim E. Allergenic potency of spices: hot, medium hot, or very hot. Int Arch Allergy Immunol 2004; 135:247-261. This is a complete and up-to-date survey on allergenic protein from spices inducing food allergy.
35. Westphal S, Kempf W, Foetisch K, et al. Tomato profilin Lye e 1: IgE cross-reactivity and allergenic potency. Allergy 2004; 59:526-532. Profilin from tomato is described for the first time. Two-thirds of sensitized subjects reported OAS. Systemic symptoms including anaphylaxis are reported in some subjects.
36. Foetisch K, Westphal S, Lauer I, et al. Biological activity of IgE specific for cross-reactive carbohydrate determinants. J Allergy Clin Immunol 2003; 111:889-896.
37. Pastorello EA, Farioli L, Pravettoni V, et al. Lipid transfer protein and vicilin are important walnut allergens in patients not allergic to pollen. J Allergy Clin Immunol 2004; 114:908-914. The authors identified allergenic molecules from walnut causing food allergy symptoms, including OAS, in patients without pollen allergy.
38. Ferreira F, Hawranek T, Gruber P, et al. Allergic cross-reactivity: from gene to the clinic. Allergy 2004; 59:243-267. This is one of the most complete reviews summarizing current knowledge on food and non-food allergens. Several aspects of allergenic molecules are reported. The new concept of co-recognition is introduced.
39. Salcedo G, Sanchez-Monge R, Diaz-Perales A, et al. Plant non-specific lipid transfer proteins as food and pollen allergens. Clin Exp Allergy 2004; 34:1336-1341. A comprehensive review on LTPs. It provides a useful update on food allergens causing symptoms from mild OAS to severe anaphylaxis.
40. Pastorello EA, Robino A. Clinical role of lipid transfer proteins in food allergy. Mol Nutr Food Res 2004; 48:356-362. This comprehensive review on clinical aspects of allergic sensitization to LTP from different sources carefully describes clinical features of LTP reactivity.
41. Crespo JF, James JM, Rodriguez J. Diagnosis and therapy of food allergy. Mol Nutr Food Res 2004; 48:347-355.
42. Akkerdaas JH, Wensing M, Knulst AC, et al. How accurate and safe is the diagnosis of hazelnut allergy by means of commercial skin prick test reagents? Int Arch Allergy Immunol 2003; 132:132-140.
43. Osterballe M, Scheller R, Skov PS, et al. Diagnostic value of scratch-chamber test, skin prick test, histamine release and specific IgE in birch-allergic patients with oral allergy syndrome to apple. Allergy 2003; 58:950-953.
44. Bohle B, Vieths S. Improving diagnostic tests for food allergy with recombinant allergens. Methods 2004; 32:292-299. This is a complete and stimulating methodological paper on the use of recombinant allergens for diagnosis of food allergens. It describes improvements and limits of the molecular diagnostic approach to class I and class II food allergies.
45. Mari A. Multiple pollen sensitization: a molecular approach to the diagnosis. Int Arch Allergy Immunol 2001; 125:57-65.
46. De Amici M, Mosca M, Vignini M, et al. Recombinant birch allergens (Bet v 1 and Bet v 2) and the oral allergy syndrome in patients allergic to birch pollen. Ann Allergy Asthma Immunol 2003; 91:490-492.
47. Asero R. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy 1998; 28:1368-1373.
48. Asero R. How long does the effect of birch pollen injection SIT on apple allergy last? Allergy 2003; 58:435-438.
49. Bucher X, Pichler WJ, Dahinden CA, Helbling A. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy 2004; 59:1272-1276. This describes an interesting study on the use of SCIT for treating OAS induced by birch pollen.
50. Asero R. Effects of birch pollen SIT on apple allergy: a matter of dosage? Allergy 2004; 59:1269-1271. An overview on specific immunotherapy trials for treatment of OAS.
51. Bolhaar ST, Tiemessen MM, Zuidmeer L, et al. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin Exp Allergy 2004; 34:761-769. The most complete and well conducted SCIT trial, evaluating efficacy on OAS. The molecular approach has been used in almost all the study phases.
52. Skamstrup Hansen K, Sondergaard KM, Stahl SP, et al. Food allergy to apple and specific immunotherapy with birch pollen. Mol Nutr Food Res 2004; 48:441-448. This was a well conducted study on the use of pollen allergenic extracts to treat associated multiple food allergies presenting as OAS.
53. Fritsch R, Bohle B, Vollmann U, et al. Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells. J Allergy Clin Immunol 1998; 102:679-686.
54. Bohle B, Radakovics A, Jahn-Schmid B, et al. Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level. Eur J Immunol 2003; 33:3303-3310.